AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling

Zähringer A, Morgado I, Erny D, Ingelfinger F, Gawron J, Chatterjee S, Wenger V, Schmidt D, Schwöbel LF, Adams RC, Langenbach M, Hartmann A, Osswald N, Wolf J, Schlunck G, Briquez PS, Grueter K, Ruess DA, Frew I, Burk A-C, Holzmüller V, Grimbacher B, Michonneau D, Andrieux G, Socié G, Kolter J, Börries M, Follo M, Blaeschke F Sevenich L, Prinz M, Zeiser R, Vinnakota JM: AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling. Blood Adv; doi: 10.1182/bloodadvances.2024015000 (2025).

Categorised in:

This post was written by redakteur